Dominic T Moore Selected Research

Dominic T Moore Research Topics

Disease

34	Neoplasms (Cancer) 01/2022 - 07/2002
20	Breast Neoplasms (Breast Cancer) 01/2023 - 07/2002
15	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2018 - 10/2002
6	Neoplasm Metastasis (Metastasis) 10/2020 - 01/2003
5	Colorectal Neoplasms (Colorectal Cancer) 12/2022 - 01/2003
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2024 - 12/2005
4	Endometrial Neoplasms (Endometrial Cancer) 02/2021 - 02/2014
4	Carcinoma (Carcinomatosis) 12/2018 - 02/2006
4	Prostatic Neoplasms (Prostate Cancer) 01/2013 - 06/2004
4	Hepatocellular Carcinoma (Hepatoma) 09/2012 - 09/2010
3	Disease Progression 12/2021 - 02/2008
3	Pathologic Complete Response 12/2021 - 04/2007
3	Obesity 02/2021 - 07/2015
3	Hematologic Neoplasms (Hematological Malignancy) 02/2021 - 07/2003
3	Renal Cell Carcinoma (Grawitz Tumor) 11/2020 - 03/2010
3	Neutropenia 01/2018 - 05/2008
3	Diarrhea 01/2018 - 05/2011
3	Multiple Myeloma 01/2017 - 03/2007
2	Lymphoma (Lymphomas) 03/2024 - 01/2005
2	Hodgkin Disease (Hodgkin's Disease) 03/2024 - 12/2005
2	Febrile Neutropenia 05/2023 - 01/2018
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2021 - 12/2005
2	Melanoma (Melanoma, Malignant) 01/2020 - 01/2008
2	Carcinosarcoma 10/2012 - 01/2006
2	Carcinogenesis 05/2012 - 11/2004
2	Esophagitis 03/2008 - 10/2002
2	Hypersensitivity (Allergy) 08/2007 - 12/2006
2	Mucositis 12/2005 - 07/2003
1	ACTH-Secreting Pituitary Adenoma 11/2023
1	Pituitary ACTH Hypersecretion 11/2023

Drug/Important Bio-Agent (IBA)

9	Carboplatin (JM8)FDA LinkGeneric 01/2018 - 10/2002
6	Paclitaxel (Taxol)FDA LinkGeneric 07/2013 - 10/2002
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 07/2002
5	Phenobarbital (Luminal)FDA Link 01/2018 - 02/2006
5	Proteins (Proteins, Gene)FDA Link 05/2012 - 01/2003
4	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
4	AnthracyclinesIBA 01/2017 - 12/2003
4	Etoposide (VP 16)FDA LinkGeneric 02/2015 - 07/2003
4	Gemcitabine FDA Link 04/2013 - 05/2008
4	ErbB Receptors (EGF Receptor)IBA 01/2013 - 01/2006
4	ParaffinIBA 01/2006 - 01/2003
3	Cetuximab (Erbitux)FDA Link 12/2022 - 08/2007
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 03/2008
3	Tyrosine Kinase InhibitorsIBA 10/2020 - 03/2010
3	Capecitabine (Xeloda)FDA Link 01/2019 - 05/2011
3	Bortezomib (Velcade)FDA Link 01/2017 - 03/2007
3	Proteasome InhibitorsIBA 01/2017 - 12/2004
3	Estrogen ReceptorsIBA 05/2013 - 02/2006
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 04/2013 - 09/2011
3	AntibodiesIBA 05/2008 - 03/2005
3	Formaldehyde (Formol)FDA Link 01/2006 - 01/2003
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2005 - 01/2003
3	Focal Adhesion Protein-Tyrosine KinasesIBA 10/2005 - 01/2003
2	Trastuzumab (Herceptin)FDA Link 01/2023 - 03/2010
2	pembrolizumabIBA 01/2022 - 12/2021
2	CurcuminIBA 01/2022 - 07/2002
2	Messenger RNA (mRNA)IBA 02/2021 - 01/2003
2	Biomarkers (Surrogate Marker)IBA 10/2020 - 12/2006
2	regorafenibIBA 10/2020 - 01/2018
2	CamptothecinIBA 01/2019 - 07/2002
2	Hematoxylin (Haematoxylon)IBA 12/2018 - 01/2013
2	Eosine Yellowish-(YS) (Eosin)IBA 12/2018 - 01/2013
2	Pemetrexed (MTA)FDA Link 01/2018 - 01/2013
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018 - 05/2011
2	liposomal doxorubicin (Doxil)FDA Link 01/2017 - 03/2007
2	PlatinumIBA 02/2015 - 06/2009
2	Albumin-Bound Paclitaxel FDA Link 02/2015 - 05/2008
2	Bevacizumab (Avastin)FDA Link 01/2013 - 11/2012
2	Tyrosine (L-Tyrosine)FDA Link 01/2013 - 01/2006
2	Androgen Receptors (Androgen Receptor)IBA 01/2013 - 01/2012
2	Phosphotransferases (Kinase)IBA 01/2013 - 01/2006
2	Sorafenib (BAY 43-9006)FDA Link 09/2012 - 03/2010
2	AZD 6244IBA 04/2012 - 06/2011
2	AndrogensIBA 01/2012 - 06/2004
2	RNA (Ribonucleic Acid)IBA 01/2008 - 01/2005
2	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2007 - 07/2002
1	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2023
1	Peptides (Polypeptides)IBA 01/2023
1	EpitopesIBA 01/2023
1	Epidermal Growth Factor (EGF)IBA 01/2023
1	VaccinesIBA 01/2023
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2023
1	palbociclibIBA 12/2022
1	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2022
1	Uridine Diphosphate (UDP)IBA 01/2022

Therapy/Procedure

24	Therapeutics 03/2024 - 09/2002
14	Drug Therapy (Chemotherapy) 12/2021 - 07/2002
11	Radiotherapy 01/2019 - 10/2002
8	Neoadjuvant Therapy 01/2019 - 09/2002
4	Stem Cell Transplantation 03/2024 - 07/2003
2	Transplantation 03/2024 - 12/2021
2	Nephrectomy 11/2020 - 03/2010
2	Mastectomy (Mammectomy) 01/2017 - 09/2002
2	Castration 01/2013 - 01/2012
2	Segmental Mastectomy (Lumpectomy) 04/2011 - 02/2011
2	Conformal Radiotherapy 01/2009 - 10/2002
2	Combined Modality Therapy 03/2008 - 04/2006
1	Salvage Therapy 03/2024
1	Hematopoietic Stem Cell Transplantation 05/2023
1	Immunotherapy 01/2023